|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/48 | |
| A61K 9/28 | |||
| A61K 31/606 | |||
| A61K 9/16 | |||
| A61K 9/20 |
| (11) | Patento numeris | 2922532 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13849986.8 |
| Europos patento paraiškos padavimo data | 2013-11-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-09-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-03-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2013/003125 |
| Data | 2013-11-19 |
| (87) | Numeris | WO 2014/091308 |
| Data | 2014-06-19 |
| (30) | Numeris | Data | Šalis |
| 201213683080 | 2012-11-21 | US |
| (72) |
BOYD, Emma, GB
CALDWELL, Deborah, Leigh, GB
COULTER, Catherine, GB
LOUGHLIN, Ryan, GB
MCCULLAGH, Stephen, GB
|
| (73) |
Allergan Pharmaceuticals International Limited,
Clonshaugh Industrial Estate Coolock, Dublin 17,
IE
|
| (54) | 5-AMINOSALICYLIC ACID CAPSULE FORMULATION |
| 5-AMINOSALICYLIC ACID CAPSULE FORMULATION |